Selank Peptide Prevented Alcohol-Induced Memory Loss by Regulating BDNF in Rat Brains
The peptide Selank protected against ethanol-induced memory and attention deficits in rats during alcohol withdrawal by normalizing BDNF levels in the hippocampus and prefrontal cortex.
Quick Facts
What This Study Found
Selank at 0.3 mg/kg/day for 7 days intraperitoneally produced a cognitive-stimulating effect in 9-month-old control rats (p<0.05) and prevented ethanol-induced memory and attention disturbances during alcohol withdrawal (p<0.01). In ex vivo brain tissue analysis, Selank prevented the ethanol-induced increase in BDNF content in both the hippocampus and frontal cortex (p<0.05). The protective effect on memory was assessed using the object recognition test, which measures both recognition memory and attention.
Key Numbers
How They Did This
Outbred rats received 10% ethanol as their sole fluid source for 30 weeks to model chronic alcohol exposure. Selank was administered intraperitoneally at 0.3 mg/kg/day for 7 days. Memory and attention were assessed using the object recognition test. BDNF content was measured ex vivo in the hippocampus and frontal cortex. Both ethanol-exposed and control (non-exposed) 9-month-old rats were tested.
Why This Research Matters
Alcohol-related cognitive impairment is a major public health problem with few effective treatments. This study suggests Selank could protect against alcohol-induced brain damage through a specific mechanism — normalizing BDNF levels. The fact that Selank also improved cognition in non-alcohol-exposed older rats suggests broader neuroprotective potential.
The Bigger Picture
Selank is a Russian-developed peptide anxiolytic based on the endogenous immune peptide tuftsin. This study adds to evidence that Selank has cognitive-enhancing properties beyond its anti-anxiety effects, specifically through BDNF-mediated neuroprotection. It fits into growing interest in peptide-based neuroprotective agents for addiction-related brain damage.
What This Study Doesn't Tell Us
This was an animal study in outbred rats, and results may not translate directly to humans. The sample size was not specified in the abstract. The 7-day treatment period is very short, and it's unclear if protection persists after Selank discontinuation. The ethanol-only fluid model is extreme and may not represent typical human drinking patterns. Selank is not FDA-approved and is primarily used in Russia.
Questions This Raises
- ?Would Selank provide similar cognitive protection in humans with alcohol use disorder during withdrawal?
- ?Why does chronic ethanol exposure increase BDNF in the hippocampus, and why does preventing this increase improve cognition?
- ?Could Selank be used as a neuroprotective adjunct during alcohol detoxification protocols?
Trust & Context
- Key Stat:
- p<0.01 memory protection Selank significantly prevented ethanol-induced memory and attention disturbances during alcohol withdrawal in rats
- Evidence Grade:
- This is a controlled animal study with statistical analysis and ex vivo mechanistic confirmation through BDNF measurement. However, it's limited to a single rat study without human validation.
- Study Age:
- Published in 2019, this study contributes to the ongoing characterization of Selank's neuroprotective properties. Selank remains primarily available in Russia and is not approved by the FDA or EMA.
- Original Title:
- Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
- Published In:
- Bulletin of experimental biology and medicine, 167(5), 641-644 (2019)
- Authors:
- Kolik, L G(2), Nadorova, A V(2), Antipova, T A, Kruglov, S V, Kudrin, V S, Durnev, A D
- Database ID:
- RPEP-04287
Evidence Hierarchy
Frequently Asked Questions
How does Selank protect against alcohol-related memory loss?
Chronic alcohol exposure disrupts BDNF, a critical brain growth factor, in the hippocampus and prefrontal cortex — areas essential for memory and attention. Selank normalized these BDNF levels, which prevented the memory and attention deficits that typically develop during alcohol withdrawal.
Does Selank improve memory in people who don't drink alcohol?
In this rat study, Selank also showed a cognitive-stimulating effect in older rats that were not exposed to alcohol, suggesting it may have general nootropic (cognitive-enhancing) properties beyond just protecting against alcohol damage. However, this has not been confirmed in human clinical trials.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04287APA
Kolik, L G; Nadorova, A V; Antipova, T A; Kruglov, S V; Kudrin, V S; Durnev, A D. (2019). Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.. Bulletin of experimental biology and medicine, 167(5), 641-644. https://doi.org/10.1007/s10517-019-04588-9
MLA
Kolik, L G, et al. "Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.." Bulletin of experimental biology and medicine, 2019. https://doi.org/10.1007/s10517-019-04588-9
RethinkPeptides
RethinkPeptides Research Database. "Selank, Peptide Analogue of Tuftsin, Protects Against Ethano..." RPEP-04287. Retrieved from https://rethinkpeptides.com/research/kolik-2019-selank-peptide-analogue-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.